Phathom Pharmaceuticals（NASDAQ:PHAT）報告本季度每股虧損$(0.79)，超過分析師共識預期的$(1.27)，提高了37.8%。這比去年同期每股虧損$(0.80)增加了1.25%。公司報告本季度銷售額爲$29.66百萬，超過分析師共識預期的$24.91百萬，增長了19.09%。這比去年同期銷售額$682,000增長了4,250%。

以上內容來自Benzinga Earnings專欄，原文如下：

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(1.27) by 37.8 percent. This is a 1.25 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $29.66 million which beat the analyst consensus estimate of $24.91 million by 19.09 percent. This is a 4.25K percent increase over sales of $682.00 thousand the same period last year.